240 research outputs found
Diseases of Cattle in Australasia: A Comprehensive Textbook
"Diseases in of Cattle in Australasia" provides cattle practitioners and veterinary students with an authoritative text on cattle diseases that may be encountered in the predominantly pasture-based environments in New Zealand and Australia. The cattle industry in Australasia is the largest animal industry in the region, and includes the dairy, pasture-fed beef, feedlot, and live-export sectors. The industry operates across a wide range of environments and production systems, and more than half of the produced dairy and beef commodities are exported.
This textbook is arranged in 25 chapters, commencing with an overview of the dairy and beef industries in New Zealand and Australia and ending with a chapter on practical therapeutics, and comes with an extensive image library on CD-ROM. The text has been mainly co-authored by Tim Parkinson, Jos Vermunt and Jakob Malmo, with additional contributions from fifteen other authors. The book is written from the perspective of the veterinary practitioner encountering the diseases in cattle on a farm. The reader is provided with a detailed outline of the diagnostic methodology based on clinical examination of body systems, with confirmation by ancillary tests and responses to treatment.
The principal authors are eminently qualified and experienced. Tim Parkinson is currently Professor of Farm Animal Reproduction and Health at Massey University in New Zealand, and a Diplomate of the European College of Animal Reproduction and Fellow of the Royal College of Veterinary Surgeons. Tim has extensive practical, academic and research experience with cattle in both the United Kingdom and New Zealand. Jos Vermunt is a registered veterinary specialist in cattle medicine and Fellow of the Australian College of Veterinary Scientists, and has combined cattle practice in (the Netherlands, Middle East, Canada, New Zealand and Australia, with academic teaching and research. Jakob Malmo is a registered veterinary specialist in cattle medicine and Fellow of the Australian College of Veterinary Scientists, and has combined a career in private practice while running two dairy farms, with teaching cattle medicine to undergraduate veterinary science students at the University of Melbourne, and supervising postgraduate students undertaking research projects in commercial dairy herds. Together, these principal authors bring a wealth of practical, academic and research experience to this text.
This is the definitive textbook on diseases of cattle in Australasia. All of the important diseases of cattle are covered, with particular emphasis on clinical examination, diseases of the gastrointestinal tract, lameness, mastitis, and reproductive disorders. The textbook will be an essential reference for cattle practitioners throughout Australia and New Zealand, and will have application where cattle are kept under similar conditions in other countries. The chapter on practical therapeutics for the c1ttle veterinarian will be of great value for veterinary students, and for the young cattle veterinarian to have in the car for reference during on-farm consultations
The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion Infection
We have previously shown that tetracyclines interact with and reverse the protease resistance of pathological prion protein extracted from scrapie-infected animals and patients with all forms of Creutzfeldt-Jakob disease, lowering the prion titre and prolonging survival of cerebrally infected animals. To investigate the effectiveness of these drugs as anti-prion agents Syrian hamsters were inoculated intramuscularly or subcutaneously with 263K scrapie strain at a 10−4 dilution. Tetracyclines were injected intramuscularly or intraperitoneally at the dose of 10 mg/kg. A single intramuscular dose of doxycycline one hour after infection in the same site of inoculation prolonged median survival by 64%. Intraperitoneal doses of tetracyclines every two days for 40 or 44 days increased survival time by 25% (doxycycline), 32% (tetracycline); and 81% (minocycline) after intramuscular infection, and 35% (doxycycline) after subcutaneous infection. To extend the therapeutic potential of tetracyclines, we investigated the efficacy of direct infusion of tetracyclines in advanced infection. Since intracerebroventricular infusion of tetracycline solutions can cause overt acute toxicity in animals, we entrapped the drugs in liposomes. Animals were inoculated intracerebrally with a 10−4 dilution of the 263K scrapie strain. A single intracerebroventricular infusion of 25 µg/ 20 µl of doxycycline or minocycline entrapped in liposomes was administered 60 days after inoculation, when 50% of animals showed initial symptoms of the disease. Median survival increased of 8.1% with doxycycline and 10% with minocycline. These data suggest that tetracyclines might have therapeutic potential for humans
Heparin Induces Harmless Fibril Formation in Amyloidogenic W7FW14F Apomyoglobin and Amyloid Aggregation in Wild-Type Protein In Vitro
Glycosaminoglycans (GAGs) are frequently associated with amyloid deposits in most amyloid diseases, and there is evidence to support their active role in amyloid fibril formation. The purpose of this study was to obtain structural insight into GAG-protein interactions and to better elucidate the molecular mechanism underlying the effect of GAGs on the amyloid aggregation process and on the related cytotoxicity. To this aim, using Fourier transform infrared and circular diochroism spectroscopy, electron microscopy and thioflavin fluorescence dye we examined the effect of heparin and other GAGs on the fibrillogenesis and cytotoxicity of aggregates formed by the amyloidogenic W7FW14 apomyoglobin mutant. Although this protein is unrelated to human disease, it is a suitable model for in vitro studies because it forms amyloid-like fibrils under physiological conditions of pH and temperature. Heparin strongly stimulated aggregation into amyloid fibrils, thereby abolishing the lag-phase normally detected following the kinetics of the process, and increasing the yield of fibrils. Moreover, the protein aggregates were harmless when assayed for cytotoxicity in vitro. Neutral or positive compounds did not affect the aggregation rate, and the early aggregates were highly cytotoxic. The surprising result that heparin induced amyloid fibril formation in wild-type apomyoglobin and in the partially folded intermediate state of the mutant, i.e., proteins that normally do not show any tendency to aggregate, suggested that the interaction of heparin with apomyoglobin is highly specific because of the presence, in protein turn regions, of consensus sequences consisting of alternating basic and non-basic residues that are capable of binding heparin molecules. Our data suggest that GAGs play a dual role in amyloidosis, namely, they promote beneficial fibril formation, but they also function as pathological chaperones by inducing amyloid aggregation
Pain Reactivity and Plasma β-Endorphin in Children and Adolescents with Autistic Disorder
International audienceBackground: Reports of reduced pain sensitivity in autism have prompted opioid theories of autism and have practical care ramifications. Our objective was to examine behavioral and physiological pain responses, plasma β-endorphin levels and their relationship in a large group of individuals with autism.Methodology/Principal Findings: The study was conducted on 73 children and adolescents with autism and 115 normal individuals matched for age, sex and pubertal stage. Behavioral pain reactivity of individuals with autism was assessed in three observational situations (parents at home, two caregivers at day-care, a nurse and child psychiatrist during blood drawing), and compared to controls during venepuncture. Plasma β-endorphin concentrations were measured by radioimmunoassay. A high proportion of individuals with autism displayed absent or reduced behavioral pain reactivity at home (68.6%), at day-care (34.2%) and during venepuncture (55.6%). Despite their high rate of absent behavioral pain reactivity during venepuncture (41.3 vs. 8.7% of controls, P<0.0001), individuals with autism displayed a significantly increased heart rate in response to venepuncture (P<0.05). Moreover, this response (Δ heart rate) was significantly greater than for controls (mean±SEM; 6.4±2.5 vs. 1.3±0.8 beats/min, P<0.05). Plasma β-endorphin levels were higher in the autistic group (P<0.001) and were positively associated with autism severity (P<0.001) and heart rate before or after venepuncture (P<0.05), but not with behavioral pain reactivity.Conclusions/Significance: The greater heart rate response to venepuncture and the elevated plasma β-endorphin found in individuals with autism reflect enhanced physiological and biological stress responses that are dissociated from observable emotional and behavioral reactions. The results suggest strongly that prior reports of reduced pain sensitivity in autism are related to a different mode of pain expression rather than to an insensitivity or endogenous analgesia, and do not support opioid theories of autism. Clinical care practice and hypotheses regarding underlying mechanisms need to assume that children with autism are sensitive to pain
Impact of milk protein type on the viability and storage stability of microencapsulated Lactobacillus acidophilus using spray drying
Three different milk proteins — skim milk powder (SMP), sodium caseinate (SC) and whey protein concentrate (WPC) — were tested for their ability to stabilize microencapsulated L. acidophilus produced using spray drying. Maltodextrin (MD) was used as the primary wall material in all samples, milk protein as the secondary wall material (7:3 MD/milk protein ratio) and the simple sugars, d-glucose and trehalose were used as tertiary wall materials (8:2:2 MD/protein/sugar ratio) combinations of all wall materials were tested for their ability to enhance the microbial and techno-functional stability of microencapsulated powders. Of the optional secondary wall materials, WPC improved L. acidophilus viability, up to 70 % during drying; SMP enhanced stability by up to 59 % and SC up to 6 %. Lactose and whey protein content enhanced thermoprotection; this is possibly due to their ability to depress the glass transition and melting temperatures and to release antioxidants. The resultant L. acidophilus powders were stored for 90 days at 4 °C, 25 °C and 35 °C and the loss of viability calculated. The highest survival rates were obtained at 4 °C, inactivation rates for storage were dependent on the carrier wall material and the SMP/d-glucose powders had the lowest inactivation rates (0.013 day−1) whilst the highest was observed for the control containing only MD (0.041 day−1) and the SC-based system (0.030 day−1). Further increase in storage temperature (25 °C and 35 °C) was accompanied by increase of the inactivation rates of L. acidophilus that followed Arrhenius kinetics. In general, SMP-based formulations exhibited the highest temperature dependency whilst WPC the lowest. d-Glucose addition improved the storage stability of the probiotic powders although it was accompanied by an increase of the residual moisture, water activity and hygroscopicity, and a reduction of the glass transition temperature in the tested systems
The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: An individual-differences perspective
The burden of proof: The current state of atrial fibrillation prevention and treatment trials
Psychophysiological sequelae of Holocaust trauma in a Jewish child
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/45673/1/11231_2005_Article_BF01253540.pd
withdrawn 2017 hrs ehra ecas aphrs solaece expert consensus statement on catheter and surgical ablation of atrial fibrillation
n/
- …